Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Bedside EEG to Evaluate Brain Injury in Premature Newborns (BrainZ)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Brigham and Women's Hospital.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Linda J. Van Marter, M.D., M.P.H., Brigham and Women's Hospital Identifier:
First received: August 13, 2007
Last updated: July 26, 2012
Last verified: July 2012
This study is evaluating whether a bedside brainwave monitor can be used to detect early brain injury in premature infants.

Brain Injury
Cerebral Palsy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Advanced Electrophysiological Studies of the Premature Newborn Infant Brain: Understanding Brain Injury

Resource links provided by NLM:

Further study details as provided by Brigham and Women's Hospital:

Estimated Enrollment: 100
Study Start Date: May 2006
Estimated Study Completion Date: May 2013
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Detailed Description:
Patient enrollment and electroencephalographic (EEG) and clinical data collection stopped May 2009. Data analysis is ongoing, and results have been described (O'Reilly D, Navakatikyan MA, Filip M, Greene D, Van Marter LJ. Peak to Peak Amplitude in Neonatal Brain Monitoring of Premature Infants. Clin Neurophysiol 2012 May 16), via publication in a peer-reviewed journal. Another manuscript has been completed and is undergoing revision for resubmission. We anticipate several additional articles will be completed from the data collected during this study. There is no relationship between industry and no current funding for this study. We maintain institutional review board approval due to ongoing data analysis.

Ages Eligible for Study:   up to 36 Months   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Infants <29 weeks gestational age

Inclusion Criteria:

  • Infants inborn below 28 weeks gestation

Exclusion Criteria:

  • At birth, deemed not likely to survive 7 days or more
  • Major intracranial congenital anomaly
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00516334

United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Brigham and Women's Hospital
Principal Investigator: Linda J Van Marter, MD, MPH Brigham and Women's Hospital
Study Director: Deirdre O'Reilly, MD, MPH Boston Children’s Hospital
  More Information

Responsible Party: Linda J. Van Marter, M.D., M.P.H., Attending Neonatologist and Associate Professor of Pediatrics Harvard Medical School, Brigham and Women's Hospital Identifier: NCT00516334     History of Changes
Other Study ID Numbers: 2003-P-000088 
Study First Received: August 13, 2007
Last Updated: July 26, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Brigham and Women's Hospital:
premature infant

Additional relevant MeSH terms:
Wounds and Injuries
Brain Injuries
Premature Birth
Cerebral Palsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Neurologic Manifestations
Signs and Symptoms
Brain Damage, Chronic processed this record on October 27, 2016